Cargando…
Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring
OBJECTIVE: To determine whether the association between depressive symptoms and glycemic control is mediated by blood glucose monitoring (BGM). RESEARCH DESIGN AND METHODS: A total of 276 adolescents with type 1 diabetes (mean age ± SD, 15.6 ± 1.4 years) completed a measure of depressive symptoms. S...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671131/ https://www.ncbi.nlm.nih.gov/pubmed/19228870 http://dx.doi.org/10.2337/dc08-2111 |
_version_ | 1782166354466439168 |
---|---|
author | McGrady, Meghan E. Laffel, Lori Drotar, Dennis Repaske, David Hood, Korey K. |
author_facet | McGrady, Meghan E. Laffel, Lori Drotar, Dennis Repaske, David Hood, Korey K. |
author_sort | McGrady, Meghan E. |
collection | PubMed |
description | OBJECTIVE: To determine whether the association between depressive symptoms and glycemic control is mediated by blood glucose monitoring (BGM). RESEARCH DESIGN AND METHODS: A total of 276 adolescents with type 1 diabetes (mean age ± SD, 15.6 ± 1.4 years) completed a measure of depressive symptoms. Sociodemographic and family characteristics were obtained from caregivers. BGM frequency and glycemic control were obtained at a clinic visit. RESULTS: Separate regression analyses revealed that depressive symptoms were associated with lower BGM frequency (B = −0.03; P = 0.04) and higher A1C (B = 0.03; P = 0.05) and that lower BGM frequency was associated with higher A1C (B = −0.39; P < 0.001). With depressive symptoms and BGM frequency included together, only BGM frequency was associated with A1C and depressive symptoms became nonsignificant (B = 0.02; P = 0.19). The Sobel test was significant (Z = 1.96; P < 0.05) and showed that 38% of the depression-A1C link can be explained by BGM. CONCLUSIONS: BGM is a mediator between depressive symptoms and glycemic control in adolescents with type 1 diabetes. |
format | Text |
id | pubmed-2671131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-26711312010-05-01 Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring McGrady, Meghan E. Laffel, Lori Drotar, Dennis Repaske, David Hood, Korey K. Diabetes Care Original Research OBJECTIVE: To determine whether the association between depressive symptoms and glycemic control is mediated by blood glucose monitoring (BGM). RESEARCH DESIGN AND METHODS: A total of 276 adolescents with type 1 diabetes (mean age ± SD, 15.6 ± 1.4 years) completed a measure of depressive symptoms. Sociodemographic and family characteristics were obtained from caregivers. BGM frequency and glycemic control were obtained at a clinic visit. RESULTS: Separate regression analyses revealed that depressive symptoms were associated with lower BGM frequency (B = −0.03; P = 0.04) and higher A1C (B = 0.03; P = 0.05) and that lower BGM frequency was associated with higher A1C (B = −0.39; P < 0.001). With depressive symptoms and BGM frequency included together, only BGM frequency was associated with A1C and depressive symptoms became nonsignificant (B = 0.02; P = 0.19). The Sobel test was significant (Z = 1.96; P < 0.05) and showed that 38% of the depression-A1C link can be explained by BGM. CONCLUSIONS: BGM is a mediator between depressive symptoms and glycemic control in adolescents with type 1 diabetes. American Diabetes Association 2009-05 2009-02-19 /pmc/articles/PMC2671131/ /pubmed/19228870 http://dx.doi.org/10.2337/dc08-2111 Text en © 2009 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details. |
spellingShingle | Original Research McGrady, Meghan E. Laffel, Lori Drotar, Dennis Repaske, David Hood, Korey K. Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring |
title | Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring |
title_full | Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring |
title_fullStr | Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring |
title_full_unstemmed | Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring |
title_short | Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring |
title_sort | depressive symptoms and glycemic control in adolescents with type 1 diabetes: mediational role of blood glucose monitoring |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671131/ https://www.ncbi.nlm.nih.gov/pubmed/19228870 http://dx.doi.org/10.2337/dc08-2111 |
work_keys_str_mv | AT mcgradymeghane depressivesymptomsandglycemiccontrolinadolescentswithtype1diabetesmediationalroleofbloodglucosemonitoring AT laffellori depressivesymptomsandglycemiccontrolinadolescentswithtype1diabetesmediationalroleofbloodglucosemonitoring AT drotardennis depressivesymptomsandglycemiccontrolinadolescentswithtype1diabetesmediationalroleofbloodglucosemonitoring AT repaskedavid depressivesymptomsandglycemiccontrolinadolescentswithtype1diabetesmediationalroleofbloodglucosemonitoring AT hoodkoreyk depressivesymptomsandglycemiccontrolinadolescentswithtype1diabetesmediationalroleofbloodglucosemonitoring |